• Rogue-River-Kayaking

    CU Cancer Center Oncologist honored at EPIC Experience Gala

    “Thank you for being a hero.” On February 7, Michael Glode, MD, CU Cancer Center…

  • katy1

    Young colon cancer patient finds hope at CU Cancer Center

    With long blonde hair, a fit physique, and an overwhelmingly positive attitude, Katy Davenport hardly…

  • Young.Cancer.Patient

    Quick Antibiotics for Fever and Low Neutrophil Count Reduces PICU Needs and Mortality of Pediatric Cancer Patients

    Changes help Children’s Hospital Colorado reduce time-to-delivery of antibiotics in pediatric cancer patients with fever and neutropenia from 150 minutes to 46 minutes.

  • CU_Cancer_Center_campus

    7th Annual Learn About Cancer Day Returns to CU Cancer Center

    The University of Colorado Cancer Center welcomed students from four different local high schools to…

  • Overwhelming evidence adds a major new target in breast cancer: androgens including testosterone. Image: Flickr/khrawlings

    In Triple-Negative Breast Cancer, Even Low-Androgen Tumors Respond to Anti-Androgen Therapy

    Valerie Barton, PhD candidate in the lab of CU Cancer Center researcher, Jennifer Richer, PhD, shows that even triple negative breast cancers with few androgen receptors respond to anti-androgen therapy.

In the Lab

In the Clinic

Meet the Experts

Marileila-Varella-Garcia-poster

A Conversation with Marileila Garcia, PhD

The goal of personalized medicine is to match the genetics of an individual’s cancer with…

Read the rest of this entry